SCHEMBL2912681

SCHEMBL2912681

COc1c(NC(=O)c2ccc(NS(C)(=O)=O)cc2Cl)cc(N2C(=O)CCNC2=O)cc1C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.38
NR1H4 Q96RI1 4/20 0.36
USP28 Q96RU2 3/20 0.36
MAPT P10636 4/20 0.35
RAB9A P51151 2/20 0.35
GAA P10253 2/20 0.35
MAPK1 P28482 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F10 P00742 1/20 0.35
HPGD P15428 1/20 0.35
MAPK14 Q16539 1/20 0.34
EPHX2 P34913 4/20 0.34
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2916517 0.91 MEN1 (0.41) CRBNNR1H4MAPTMAPK1ALDH1A1
SCHEMBL2910562 0.88 HPGD (0.41) CRBNMAPTRAB9AMAPK1ALDH1A1
SCHEMBL2915057 0.86 CRBN (0.39) CRBNMAPTRAB9AGAAMAPK1
SCHEMBL2907766 0.85 KMT2A (0.41) CRBNNR1H4MAPTRAB9AMAPK1
SCHEMBL1530899 0.83 AURKB (0.41) CRBNNR1H4MAPTRAB9AGAA
SCHEMBL2913169 0.81 CRBN (0.40) CRBNNR1H4MAPTGAAMAPK1
SCHEMBL2914837 0.80 KMT2A (0.41) CRBNNR1H4MAPTRAB9AMAPK1
SCHEMBL2915689 0.80 F10 (0.39) CRBNMAPTRAB9AMAPK1ALDH1A1
SCHEMBL2913875 0.79 F10 (0.37) CRBNNR1H4MAPTRAB9AGAA
SCHEMBL2910630 0.78 MEN1 (0.46) NR1H4MAPTRAB9AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2725015-A1 Uracil or thymine derivative for treating hepatitis c AbbVie Bahamas Ltd. (BS) 2014-04-30 EP claimed
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed